ArticleOne health (Amsterdam, Netherlands)2022
Evaluation of dogs (
Article in One health (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.
- Mosquito vector competence for Japanese encephalitis virus: a systematic review and meta-analysis update.Parasites & vectors · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Japanese encephalitis (JE) is a mosquito-borne zoonotic neurological disease caused by Japanese encephalitis virus (JEV). JEV is the most common cause of viral encephalitis in Southeast Asia and the Western Pacific Rim. The fatality rate due to JE can reach 25% and up to 50% of the patients who survive develop permanent neurological damage. The annual incidence of human JE markedly increased in the Republic of Korea (ROK) in 2010 but the reason for the reemergence of JE in the ROK has not been established. This study aimed to assess the extent of exposure of domestic dogs to JEV in the Seoul metropolitan area, one of the most populated areas in the world. This cross-sectional study serologically investigated the spread of JEV in the dog population. Using serum neutralization test, we examined 3597 serum samples collected from pet, shelter, stray, and farmed dogs in the Seoul metropolitan area from 2006 to 2012. JEV-neutralizing antibodies found in shelter, stray, and farmed dogs sampled in approximately 2010 demonstrated increased JEV circulation in the dog population during the 2010 resurgence of JE reported among humans in the ROK. Five out of 1102 pet dogs (0.5%) were found to be neutralizing antibodies against JEV and 24 of 719 shelter dogs (3.1%) were positive with a peak of 13.0% in 2010. In addition, 25 of 690 stray dogs (3.6%) were positive with a peak of 9.7% in 2009, a year before the 2010 resurgence of JE. Furthermore, 39 of 1086 farmed dogs (3.6%) were seropositive with a peak of 9.2% in 2009. We therefore suggest that monitoring dog populations for seroconversion or seropositive dogs within JEV-active endemic areas may be useful for identifying risk areas for JE outbreaks and that JEV activity in dogs can be an indicator as the harbingers of JEV in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.